Concepedia

Publication | Open Access

Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study

DOIFull Paper Access

110

Citations

6

References

2014

Year

Christian Jackisch, S.-B. Kim, Semiglazov Vf, Bohuslav Melichar, Xavier Pivot, Carina Hillenbach, Daniil Stroyakovskiy, B L Lum, Robert S. Elliott, Harald Weber,
Annals of Oncology

References

YearCitations

Page 1